• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of amolbioBioMed CentralBiomed Central Web Sitesearchsubmit a manuscriptregisterthis articleAlgorithms for Molecular Biology : AMB
Algorithms Mol Biol. 2008; 3: 8.
Published online Jun 26, 2008. doi:  10.1186/1748-7188-3-8
PMCID: PMC2464587

A weighted average difference method for detecting differentially expressed genes from microarray data

Abstract

Background

Identification of differentially expressed genes (DEGs) under different experimental conditions is an important task in many microarray studies. However, choosing which method to use for a particular application is problematic because its performance depends on the evaluation metric, the dataset, and so on. In addition, when using the Affymetrix GeneChip® system, researchers must select a preprocessing algorithm from a number of competing algorithms such as MAS, RMA, and DFW, for obtaining expression-level measurements. To achieve optimal performance for detecting DEGs, a suitable combination of gene selection method and preprocessing algorithm needs to be selected for a given probe-level dataset.

Results

We introduce a new fold-change (FC)-based method, the weighted average difference method (WAD), for ranking DEGs. It uses the average difference and relative average signal intensity so that highly expressed genes are highly ranked on the average for the different conditions. The idea is based on our observation that known or potential marker genes (or proteins) tend to have high expression levels. We compared WAD with seven other methods; average difference (AD), FC, rank products (RP), moderated t statistic (modT), significance analysis of microarrays (samT), shrinkage t statistic (shrinkT), and intensity-based moderated t statistic (ibmT). The evaluation was performed using a total of 38 different binary (two-class) probe-level datasets: two artificial "spike-in" datasets and 36 real experimental datasets. The results indicate that WAD outperforms the other methods when sensitivity and specificity are considered simultaneously: the area under the receiver operating characteristic curve for WAD was the highest on average for the 38 datasets. The gene ranking for WAD was also the most consistent when subsets of top-ranked genes produced from three different preprocessed data (MAS, RMA, and DFW) were compared. Overall, WAD performed the best for MAS-preprocessed data and the FC-based methods (AD, WAD, FC, or RP) performed well for RMA and DFW-preprocessed data.

Conclusion

WAD is a promising alternative to existing methods for ranking DEGs with two classes. Its high performance should increase researchers' confidence in microarray analyses.

Background

One of the most common reasons for analyzing microarray data is to identify differentially expressed genes (DEGs) under two different conditions, such as cancerous versus normal tissue [1]. Numerous methods have been proposed for doing this [2-27], and several evaluation studies have been reported [28-32]. A prevalent approach to such an analysis is to calculate a statistic (such as the t-statistic or the fold change) for each gene and to rank the genes in accordance with the calculated values (e.g., the method of Tusher et al. [3]). A large absolute value is evidence of a differential expression. Inevitably, different methods (statistics) generally produce different gene rankings, and researchers have been troubled about the differences. Another approach is to rank genes in accordance with their predictive accuracy such as by performing gene-by-gene prediction [24].

Although the two approaches are not mutually exclusive, their suitabilities differ; the former approach is better when the identified DEGs are to be investigated for a follow-up study [24], and the latter is better when a classifier or predictive model needs to be developed for class prediction [17]. The method presented in this paper focuses on the former approach – many "wet" researchers want to rank the true DEGs as high as possible, and the former approach is more suitable for that purpose.

Methods for ranking genes in accordance with their degrees of differential expression can be divided into t-statistic-based methods and fold-change (FC)-based methods. Both types are commonly used for selecting DEGs with two classes. They each have certain disadvantages. The t-statistic-based gene ranking is deficient because a gene with a small fold change can have a very large statistic for ranking, due to the t-statistic possibly having a very small denominator [24]. The FC-based ranking is deficient because a gene with larger variances has a higher probability of having a larger statistic [24]. From our experience, a disadvantage that they share is that some top-ranked genes which are falsely detected as "differentially expressed" tend to exhibit lower expression levels. This interferes with the chance of detecting the "true" DEGs because the relative error is higher at lower signal intensities [4,33-36]. Although many researchers have addressed this problem, false positives remain to some extent in the subset of top-ranked genes.

Our weighted average difference (WAD) method was designed for accurate gene ranking. We evaluated its performance in comparison with those of the average difference (AD) method, the FC method, the rank products (RP) method [12,37], the moderated t statistic (modT) method [9], the significance analysis of microarrays t statistic (samT) method [3], the shrinkage t statistic (shrinkT) method [23], and the intensity-based moderated t statistic (ibmT) method [20] by using datasets with known DEGs (Affymetrix spike-in datasets and datasets containing experimentally validated DEGs).

Results and discussion

The evaluation was mainly based on the area under the receiver operating characteristic (ROC) curve (AUC). The AUC enables comparisons without a trade-off in sensitivity and specificity because the ROC curve is created by plotting the true positive (TP) rate (sensitivity) against the false positive (FP) rate (1 minus the specificity) obtained at each possible threshold value [38-40]. This is one of the most important characteristics of a method. The evaluation was performed using 38 different datasets [41-73] containing true DEGs that enabled us to determine the TP and FP.

Seven methods were used for comparison: AD was used to evaluate the effect of the "weight" term in WAD (see the Methods section), FC was recommended by Shi et al. [74], RP [12] and modT [9] were recommended by Jeffery et al. [29], samT [3] is a widely used method, and shrinkT [23] and ibmT [20] were recently proposed at the time of writing. All programming was done in R [75] using Bioconductor [76].

Datasets

The evaluation used two publicly available spike-in datasets [41,42] (Datasets 1 and 2) and 36 experimental datasets that each had some true DEGs confirmed by real-time polymerase chain reaction (RT-PCR) [43-73] (Dataset 3–38). The first two datasets are well-chosen sets of data from other studies [20,23]. Dataset 1 is a subset of the completely controlled Affymetrix spike-in study done on the HG-U95A array [41], which contains 12,626 probesets, 12 technical replicates of two different states of samples, and 16 known DEGs. The details of this experiment are described elsewhere [41]. The subset was extracted from the original sets by following the recommendations of Opgen-Rhein and Strimmer [23]. Dataset 2 was produced from the Affymetrix HG-U133A array, which contains 22,300 probesets, three technical replicates of 14 different states of samples, and 42 known DEGs. Accordingly, there were 91 possible comparisons (14C2 = 91). Dataset 2 was evaluated on the basis of the average values of the 91 results.

Since these experiments (using Datasets 1 and 2) were performed using the Affymetrix GeneChip® system, one of several available preprocessing algorithms (such as Affymetrix Microarray Suite version 5.0 (MAS) [77], robust multichip average (RMA) [38], and distribution free weighted method (DFW) [40]) could be applied to the probe-level data (.CEL files). We used these three algorithms to preprocess the probe-level data; MAS and RMA are most often used for this purpose, and DFW is currently the best algorithm [40]. Of these, DFW is essentially a summarization method and its original implementation consists of following steps: no background correction, quantile normalization (same as in RMA), and DFW summarization. The probeset summary scores for Datasets 1 and 2 are publicly available on-line [42]. Accordingly, a total of six datasets were produced from Datasets 1 and 2, i.e., Dataset x (MAS), Dataset x (RMA), Dataset x (DFW), where x = 1 or 2.

Datasets 3–38 were produced from the Affymetrix HG-U133A array, which is currently the most used platform. All of the datasets consisted of two different states of samples (e.g., cancerous vs. non-cancerous) and the number of samples in each state was > = 3. Each dataset had two or more true DEGs and these DEGs were originally detected on MAS- or RMA-preprocessed data. The raw (probe-level) data are also publicly available from the Gene Expression Omnibus (GEO) website [78]. One can preprocess the raw data using the MAS, RMA, and DFW algorithms. Detailed information on these datasets is given in the additional file [see Additional file 1].

Evaluation using spike-in datasets (Datasets 1 and 2)

The AUC values for the eight methods for Datasets 1 and 2 are shown in Table Table1.1. Overall, WAD outperformed the other methods. It performed the best for five of the six datasets and ranked no lower than fourth best for all datasets. RP performed the best for Dataset 2 (RMA). The R-codes for analyzing these datasets are available in the additional files [see Additional files 2 and 3].

Table 1
AUC (percent) values for Datasets 1 and 2 for eight methods

The largest difference between WAD and the other methods was observed for Dataset 1 (MAS). Because MAS uses local background subtraction, MAS-preprocessed data tend to have extreme variances at low intensities. As shown in Table Table2,2, increasing the floor values for the MAS-preprocessed data increased the AUC values for all methods except WAD. Nevertheless, the AUC values for WAD at the four intensity thresholds were clearly higher than those for the other methods. These results indicate that the advantage of WAD over the other methods is not merely due to a defect in the MAS algorithm.

Table 2
AUC (percent) values for Dataset 1 (MAS) for different signal intensity thresholds

The basic assumption of WAD is that "strong signals are better signals." This assumption may unfairly favorable when spike-in datasets are used for evaluation. One can only spike mRNA at rather high concentrations because of technical limitations such as mRNA stability and pipetting accuracy, meaning that spike-in transcripts tend to have strong signals [79]. The basic assumption is therefore necessarily true for spike-in data. Indeed, a statistic based on the relative average signal intensity (e.g., a statistic based on the "weight" term, w, in the WAD statistic; see Methods) for Dataset 1 (MAS) could, for example, give a very high AUC value of 90.0%. We also observed high AUC values based on the w statistic for the RMA- (87.3% of AUC) and DFW-preprocessed data (80.4%).

Evaluation using experimental datasets (Datasets 3–38)

Nevertheless, we have seen that several well-known marker genes and experimentally validated DEGs tend to have strong signals, which supports our basic assumption. If there is no correlation between differential expression and expression level, the AUC value based on the w statistic should be approximately 0.5. Actually, of the 36 experimental datasets, 34 had AUC values > 0.5 when the w statistic was used (Figure (Figure1,1, light blue circle) and the average AUC value was high (72.7%). These results demonstrate the validity of our assumption.

Figure 1
Effect of the weight (w) term in WAD statistic for 36 real experimental datasets (Datasets 3–38). AUC values for the weight term (w, light blue circle) in WAD, AD (black circle), and WAD (red circle) are shown. Analyses of Datasets 3–26 ...

This high AUC value may not be due to the microarray technology because any technology is unreliable at the low intensity/expression end. Inevitably, genes that can be confirmed as DEGs using a particular technology tend to have high signal intensity. That is, it is difficult to confirm candidate genes having low signal intensity [48,80]. Whether a candidate is a true DEG must ultimately be decided subjectively. Therefore, many candidates having low signal intensity should not be considered true DEGs.

Apart from the above discussion, a good method should produce high AUC values for real experimental datasets. The analysis of Datasets 3–38 showed that the average AUC value for WAD (96.737%) was the highest of the eight methods when the preprocessing algorithms were selected following the original studies (Table (Table3).3). WAD performed the best for 12 of the 36 experimental datasets.

Table 3
Results for Dataset 3–38 using eight methods

The 36 experimental datasets can be divided into two groups: One group (Datasets 3–26) had originally been analyzed using MAS-preprocessed data and the other (Datasets 27–38) had originally been analyzed using RMA-preprocessed data. Table Table44 shows the average AUC values for MAS-, RMA-, and DFW-preprocessed data for the two groups (Datasets 3–26 and Datasets 27–38). The values for the MAS- (RMA-) preprocessed data for the first (second) group were overall the best among the three preprocessing algorithms. This is reasonable because the best performing algorithms were practically used in the original papers [43-73]. The exception was for RP [12] in the first group: the average AUC values for RMA- (92.540) and DFW-preprocessed data (92.534) were higher than the value for MAS-preprocessed data (91.511).

Table 4
Average AUC values for Datasets 3–26 and 27–38

Interestingly, the FC-based methods (AD, WAD, FC, and RP) were generally superior to the t-statistic-based methods (modT, samT, shrinkT, and ibmT) when RMA- or DFW-preprocessed data were analyzed. This is probably because the RMA and DFW algorithms simultaneously preprocess data across a set of arrays to improve the precision of the final measures of expression [81] and include a variance stabilization step [38,40]. Accordingly, some variance estimation strategies employed in the t-statistic-based methods may be no longer necessary for such preprocessed data. Indeed, the t-statistic-based methods were clearly superior to the FC-based methods (except WAD) when the MAS-preprocessed data were analyzed: The MAS algorithm considers data on a per-array basis [77] and has been criticized for its exaggerated variance at low intensities [82].

It should be noted that we cannot compare the three preprocessing algorithms with the results from the 36 real experimental datasets. One might think the RMA algorithm is the best among the three algorithms because (1) the average AUC values for the RMA (the average is 91.978) were higher than those for DFW (91.274) in the results for Datasets 3–26 and (2) the average AUC values for DFW (93.465) were also higher than those for MAS (89.587) in the results for Datasets 27–38 (Table (Table4).4). However, the lower average AUC values for DFW compared with the RMA in the results for Datasets 3–26 were mainly due to the poor affinity between the t-statistic-based methods and the DFW algorithm. The average AUC values for DFW were quite similar to those for RMA only when the FC-based methods were compared. In addition, the higher average AUC values for DFW (93.465) than for MAS in the results for Datasets 27–38 were rather by virtue of the similarity of data processing to RMA: DFW employs the same background correction and normalization procedures as RMA, and the only difference between the two algorithms is in their summarization procedure.

It should also be noted that there must be many additional DEGs in the 36 experimental datasets because the RT-PCR validation is performed only for a subset of top-ranked genes. Accordingly, we cannot compare the eight methods by using other evaluation metrics such as the false discovery rate (FDR) [83] or compare their abilities of identifying new genes that might have been missed in a previous analysis. Such comparisons could also produce different results with different parameters such as number of top ranked genes or different gene ranking methods used in the original study. For example, the FC-based methods (AD, WAD, FC, and RP) and the t-statistic-based methods (modT, samT, shrinkT, and ibmT) produce clearly dissimilar gene lists (see Table Table5).5). This difference suggests that the FC-based methods should be advantageous for six datasets (Datasets 3–6 and 27–28) whose gene rankings were originally performed with only the FC-based methods. Likewise, the t-statistic-based methods should be advantageous for 15 datasets (Datasets 19–26 and 32–38). The RT-PCR validation for a subset of potential DEGs were based on those gene ranking results. Indeed, the average rank (3.92) of AUC values for the FC-based methods on the six datasets and for the t-statistic-based methods on the 15 datasets was clearly higher than that (5.08) for the t-statistic-based methods on the six datasets and for the FC-based methods on the 15 datasets (p-value = 0.001, Mann-Whitney U test). This implies a comparison using a total of the 21 datasets (Datasets 3–6, 19–28, and 32–38) should give an advantageous result for the t-statistic-based methods since those methods were used in the original analysis for 15 of the 21 datasets. Nevertheless, the best performing methods across the 36 experimental datasets including the 21 datasets seem to be independent of the originally analyzed methods, by virtue of WAD's high performance. Also, the overall performances of eight methods for the two artificial spike-in datasets (Datasets 1 and 2) and for the 36 real experimental datasets (Datasets 3–38) were quite similar (Tables (Tables11 and and4).4). These results suggest that the use of genes only validated by RT-PCR as DEGs does not affect the objective evaluations of the methods.

Table 5
Average number of genes common to each pair of methods for Datasets 3–38

To our knowledge, the number (32) of real experimental datasets we analyzed is much larger than those analyzed by previous methodological studies: Two experimental datasets were evaluated for the ibmT [20] method and one was for the shrinkT [23] method. Although those studies performed a profound analysis on a few datasets, we think a superficial comparison on a large number of experimental datasets is more important than a profound one on a few experimental datasets when estimating the methods' practical ability to detect DEGs, as the superficial comparison on a large number of datasets can also prevent selection bias regarding the datasets. Therefore, we think the number of experimental datasets interrogated is also very important for evaluating the practical advantages of the existing methods. A profound comparison on a large number of experimental datasets should be of course the most important. For example, a comparison of significant Gene Ontology [84] categories using top-ranked genes from each of the eight methods would be interesting. We think such a comparison would be important as another reasonable assessment of whether some top-ranked genes detected only by WAD might actually be differentially expressed. The analysis of many datasets is however practically difficult because of wide range of knowledge it would require, and this related to the next task.

Effect of different preprocessing algorithms on gene ranking

In general, different choices of preprocessing algorithms can output different subsets of top-ranked genes (e.g., see Tables Tables11 and and4)4) [85]. We compared the gene rankings of MAS-, RMA-, and DFW-preprocessed data. Table Table66 shows the average number of common genes in 20, 50, 100, and 200 top-ranked genes for the 36 experimental datasets. Although all methods output relatively low numbers of common genes, the numbers for WAD were consistently higher than those for the other methods. This result indicates the gene ranking based on WAD is more robust against data processing than the other methods are.

Table 6
Average number of common genes in results of three preprocessing algorithms for Datasets 3–38

From the comparison of WAD and AD, it is obvious that the high rank-invariant property of WAD is by virtue of the inclusion of the weight term: The gene ranking based on the w statistic is much more reproducible than the one based on the AD statistic. Relatively small numbers of common genes were observed for the other FC-based methods (AD, FC, and RP) (Table (Table6).6). This was because differences in top-ranked genes between MAS and RMA (or DFW) were much larger than those between RMA and DFW (data not shown).

Effect of outliers on the weight term in WAD statistic

Recall that the WAD statistic is composed of the AD statistic and the weight (w) term (see the Methods section). Some researchers may be suspicious about the use of w because it is calculated from a sample mean (i.e., xi¯) for gene i, and sample means are notoriously sensitive to outliers in the data. Actually, the w term is calculated from logged data and is therefore insensitive to outliers. Indeed, we observed few outliers in two datasets (there were 31 outliers in Dataset 14 and 7 outliers in Dataset 29; they corresponded to (31 + 7)/(22,283 clones × 36 datasets) = 0.0047%) when an outlier detection method based on Akaike's Information Criterion (AIC) [85-87] was applied to the average expression vector (x1¯,...,xp¯) calculated from each of the 36 datasets. In addition to the automatic detection of outliers, we also visually examined the distribution of the average vectors and concluded there were no outliers. Also, the differences in the AUC values between AD and WAD were less than 0.1% for the two datasets (Datasets 14 and 29). We therefore decided that all the automatically detected outliers did not affect the result. The average expression vectors and the results of outlier detection using the AIC-based method are available in the additional files [see Additional files 4 and 5].

Choice of best methods with preprocessing algorithms

In this study, we analyzed eight gene-ranking methods with three preprocessing algorithms. Currently, there is no convincing rationale for choosing among different preprocessing algorithms. Although the three algorithms from best to worst were DFW, RMA, and MAS when artificial spike-in datasets (Datasets 1 and 2) were evaluated using the AUC metric with the eight methods (Table (Table1),1), their performance might not be generalizable in practice [79]. Indeed, a recent study reported the utility of MAS [82]. Also, a shared disadvantage of RMA and DFW is that the probeset intensities change when microarrays are re-preprocessed because of the inclusion of additional arrays, but modification strategies to deal with it have only been developed for RMA [81,88,89]. We therefore discuss the best methods for each preprocessing algorithm.

For MAS users, we think WAD is the most promising method because it gave good results for both types of dataset (artificial spike-in and real experimental datasets, see Tables Tables1,1, ,2,2, and and4).4). The second best was ibmT [20]. Although there was no a statistically significant difference between the 36 AUC values for WAD from the real experimental datasets and those for the second best method (ibmT) (one-tail p-value = 0.18, paired t-test; see Table Table7a),7a), it is natural that one should select the best performing method for a number of real datasets.

Table 7
Statistical significance between two methods for Datasets 3–38

For RMA users, FC-based methods can be recommended. Although these methods (except WAD) were inferior to the t-statistic-based methods when the results for the older spike-in dataset (Dataset 1, which is obtained from the HG-U95A array) were compared, they were better for both the newer spike-in dataset (Dataset 2, which is from the HG-U133A array) and the 36 real experimental datasets (Datasets 3–38, which is also from the HG-U133A array). We think that the results for the real experimental datasets (or a newer platform) should take precedence over the results for the artificial datasets (or an older platform). AD or FC may be the best since they are the best for the 36 real datasets (see Tables Tables44 and and7b7b).

For DFW users, RP can be recommended since it was the best for the 36 real experimental datasets (see Tables Tables44 and and7c).7c). However, the use of RP for analyzing large numbers of arrays can be sometimes limited by available computer memory. The other FC-based methods can be recommended for such a situation.

The variance estimation is much more challenging when the number of replicates is small [29]. This suggests that the FC-based methods including WAD tend to be more powerful (or less powerful) than the t-statistic-based methods if the number of replicates is small (or large). We found that WAD was the best for some datasets which contain large (> 10) replicates (e.g., Datasets 5, 7, and 26) while FC and RP tended to perform the best on datasets with relatively small replicates (e.g., Datasets 34 and 10, whose numbers of replicates in one class were smaller than 6) [see Additional file 1]. These results suggest that WAD can perform well across a range of replicate numbers.

It is important to mention that there are other preprocessing algorithms such as FARMS [39] and SuperNorm [90]. FARMS considers data on a multi-array basis as does RMA and DFW, while SuperNorm considers data on a per-array basis as does MAS. Although the FC-based methods were superior to the t-statistic-based methods, the latter methods might perform well for FARMS- or SuperNorm-preprocessed data. The evaluation of competing methods for these preprocessing algorithms will be our next task.

In practice, one may want to detect the DEGs from gene expression data, produced from a comparison of two or more classes (or time points), and the current method does not analyze these DEGs. A simple way to deal with them is to use AD(i)=max(xiq¯)min(xiq¯) and xi¯=mean(xiq¯) in WAD for the q class problem (q = 1, 2, 3, ...) (see the Methods section for details). Of course, there are many possible ways to analyze these DEGs. Further work is needed to make WAD universal.

Conclusion

We proposed a new method (called WAD) for ranking differentially expressed genes (DEGs) from gene expression data, especially obtained by Affymetrix GeneChip® technology. The basic assumption for WAD was that strong signals are better signals. We demonstrated that known or potential marker genes had high expression levels on average in 34 of the 36 real experimental datasets and applied our idea as the weight term in the WAD statistic.

Overall, WAD was more powerful than the other methods in terms of the area under the receiver operating characteristic curve. WAD also gave consistent results for different preprocessing algorithms. Its performance was verified using a total of 38 artificial spike-in datasets and real experimental datasets. Given its excellent performance, we believe that WAD should become one of the methods used for analyzing microarray data.

Methods

Microarray data

The processed data (MAS-, RMA-, and DFW-preprocessed data) for Datasets 1 and 2 were downloaded from the Affycomp II website [42]. The raw (probe level) data for Dataset 3–38 were obtained from the Gene Expression Omnibus (GEO) website [78]. All analyses were performed using log2-transformed data except for the FC analysis. In Datasets 3–38, the 'true' DEGs were defined as those differential expressions that had been confirmed by real-time polymerase chain reaction (RT-PCR). For example, we defined 16 probesets (corresponding to 15 genes) of 20 candidates as DEGs in Dataset 9 [48] because the remaining four probesets (or genes) showed incompatible expression patterns between RT-PCR and the microarray. For reproducibility, detailed information on these datasets is given in the additional file [see Additional file 1].

Weighted Average Difference (WAD) method

Consider a gene expression matrix consisting of p genes and n arrays, produced from a comparison between classes A and B. The average difference (ADi=xiB¯xiA¯), defined here as the average log signal for all class B replicates (xiB¯) minus the average log signal for all class A replicates (xiA¯), is an obvious indicator for estimating the differential expression of the ith gene, xi=(xi1,...,xin). Some of the top-ranked genes from the simple statistic, however, tend to exhibit lower expression levels. This is not good because the signal-to-noise ratio decreases with the gene expression level [3] and because known DEGs tend to have high expression levels.

To account for these observations, we use relative average log signal intensity wi for weighting the average difference in xi.

wi=xi¯minmaxmin,
(1)

where xi¯ is calculated as (xiA¯+xiB¯)/2, and the max (or min) indicates the maximum (or minimum) value in an average expression vector (x1¯,...,xp¯) on a log scale.

The WAD statistic for the ith gene, WAD(i), is calculated simply as

WAD(i) = ADi × wi.
(2)

The basic assumption for our approach to the gene ranking problem is that ''strong signals are better signals'' [36]. The WAD statistic is a straightforward application of this idea. The R-source codes for analyzing Datasets 1 and 2 are available in additional files [see Additional files 2 and 3].

Fold change (FC) method

The FC statistic for the ith gene, FC(i), was calculated as the average non-log signal for all class B replicates divided by the average non-log signal for all class A replicates. The ranking for selecting DEGs was performed using the log of FC(i).

Rank products (RP) method

The RP method is an FC-based method. The RP statistic was calculated using the RP() function in the "RankProd" library [37] in R [75] and Bioconductor [76].

Moderated t-statistic (modT) method

The modT method is an empirical Bayes modification of the t-test [9]. The modT statistic was calculated using the modt.stat() function in the "st" library [23] in R [75].

Significance analysis of microarrays (samT) method

The samT method is a modification of the t-test [3], and it works by adding a small value to the denominator of the t statistic. The samT statistic was calculated using the sam.stat() function in the "st" library [23] in R [75].

Shrinkage t-statistic (shrinkT) method

The shrinkT method is a quasi-empirical Bayes modification of the t-test [23]. The shrinkT statistic was calculated using the shrinkt.stat() function in the "st" library [23] in R [75].

Intensity-based moderated t-statistic (ibmT) method

The ibmT method is a modified version of the modT method [20]. The ibmT statistic was calculated using the IBMT() function, available on-line [91].

Abbreviations

AUC: area under ROC curve; DEG: differentially expressed gene; DFW: distribution-free weighted (method); FC: fold change; FP: false positive; ibmT: intensity-based moderated t-statistic; MAS: (Affymetrix) MicroArray Suite version 5; modT: moderated t-statistic; RMA: robust multi-chip average; ROC: receiver operating characteristic; RP: rank products; samT: significance analysis of microarrays; shrinkT: shrinkage t-statistic; TP: true positive; WAD: weighted average difference (method)

Authors' contributions

KK developed the method and wrote the paper, YN and KS provided critical comments and led the project.

Supplementary Material

Additional file 1:

Detailed information for Datasets 3–38.

Additional file 2:

R-code for analyzing Dataset 1.

Additional file 3:

R-code for analyzing Dataset 2.

Additional file 4:

Average expression vectors and the results of outlier detection for Datasets 3–26. Sheet 1: Average expression vectors are provided. Sheet 2: For each of the original average expression vectors, an outlier vector (consisting of 1 for over-expressed outliers, -1 for under-expressed outliers, and 0 for non-outliers) is provided. This sheet does not contain "-1".

Additional file 5:

Average expression vectors and the results of outlier detection for Datasets 27–38. Sheet 1: Average expression vectors are provided. Sheet 2: For each of the original average expression vectors, an outlier vector (consisting of 1 for over-expressed outliers, -1 for under-expressed outliers, and 0 for non-outliers) is provided. This sheet does not contain "-1".

Acknowledgements

This study was supported by Special Coordination Funds for Promoting Science and Technology and by KAKENHI (19700273) to KK from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT).

References

  • Feten G, Aastveit AH, Snipen L, Almoy T. A discussion concerning the inclusion of variety effect when analysis of variance is used to detect differentially expressed genes. Gene Regulation Systems Biol. 2007;1:43–47. [PMC free article] [PubMed]
  • Kerr MK, Martin M, Churchill GA. Analysis of variance for gene expression microarray data. J Comput Biol. 2000;7:819–837. doi: 10.1089/10665270050514954. [PubMed] [Cross Ref]
  • Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA. 2001;98:5116–5121. doi: 10.1073/pnas.091062498. [PMC free article] [PubMed] [Cross Ref]
  • Baldi P, Long AD. A Bayesian framework for the analysis of microarray expression data: regularized t-test and statistical inference of gene changes. Bioinformatics. 2001;17:509–519. doi: 10.1093/bioinformatics/17.6.509. [PubMed] [Cross Ref]
  • Li L, Weinberg C, Darden T, Pedersen L. Gene selection for sample classification based on gene expression data: study of sensitivity to choice of parameters of the GA/KNN method. Bioinformatics. 2001;17:1131–1142. doi: 10.1093/bioinformatics/17.12.1131. [PubMed] [Cross Ref]
  • Pavlidis P, Noble WS. Analysis of strain and regional variation in gene expression in mouse brain. Genome Biol. 2001;2:RESEARCH0042. doi: 10.1186/gb-2001-2-10-research0042. [PMC free article] [PubMed] [Cross Ref]
  • Efron B, Tibshirani R. Empirical bayes methods and false discovery rates for microarrays. Genet Epidemiol. 2002;23:70–86. doi: 10.1002/gepi.1124. [PubMed] [Cross Ref]
  • Parodi S, Muselli M, Fontana V, Bonassi S. ROC curves are a suitable and flexible tool for the analysis of gene expression profiles. Cytogenet Genome Res. 2003;101:90–91. doi: 10.1159/000074404. [PubMed] [Cross Ref]
  • Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004;3:Article 3. [PubMed]
  • Martin DE, Demougin P, Hall MN, Bellis M. Rank Difference Analysis of Microarrays (RDAM), a novel approach to statistical analysis of microarray expression profiling data. BMC Bioinformatics. 2004;5:148. doi: 10.1186/1471-2105-5-148. [PMC free article] [PubMed] [Cross Ref]
  • Cho JH, Lee D, Park JH, Lee IB. Gene selection and classification from microarray data using kernel machine. FEBS Lett. 2004;571:93–98. doi: 10.1016/j.febslet.2004.05.087. [PubMed] [Cross Ref]
  • Breitling R, Armengaud P, Amtmann A, Herzyk P. Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments. FEBS Lett. 2004;573:83–92. doi: 10.1016/j.febslet.2004.07.055. [PubMed] [Cross Ref]
  • Breitling R, Herzyk P. Rank-based methods as a non-parametric alternative of the T-statistic for the analysis of biological microarray data. J Bioinform Comput Biol. 2005;3:1171–1189. doi: 10.1142/S0219720005001442. [PubMed] [Cross Ref]
  • Yang YH, Xiao Y, Segal MR. Identifying differentially expressed genes from microarray experiments via statistic synthesis. Bioinformatics. 2005;21:1084–1093. doi: 10.1093/bioinformatics/bti108. [PubMed] [Cross Ref]
  • Smyth GK, Michaud J, Scott HS. Use of within-array replicate spots for assessing differential expression in microarray experiments. Bioinformatics. 2005;21:2067–2075. doi: 10.1093/bioinformatics/bti270. [PubMed] [Cross Ref]
  • Hein AM, Richardson S. A powerful method for detecting differentially expressed genes from GeneChip arrays that does not require replicates. BMC Bioinformatics. 2006;7:353. doi: 10.1186/1471-2105-7-353. [PMC free article] [PubMed] [Cross Ref]
  • Baker SG, Kramer BS. Identifying genes that contribute most to good classification in microarrays. BMC Bioinformatics. 2006;7:407. doi: 10.1186/1471-2105-7-407. [PMC free article] [PubMed] [Cross Ref]
  • Lewin A, Richardson S, Marshall C, Glazier A, Aitman T. Bayesian modeling of differential gene expression. Biometrics. 2006;62:1–9. doi: 10.1111/j.1541-0420.2005.00394.x. [PubMed] [Cross Ref]
  • Gottardo R, Raftery AE, Yeung KY, Bumgarner RE. Bayesian robust inference for differential gene expression in microarrays with multiple samples. Biometrics. 2006;62:10–18. doi: 10.1111/j.1541-0420.2005.00397.x. [PubMed] [Cross Ref]
  • Sartor MA, Tomlinson CR, Wesselkamper SC, Sivaganesan S, Leikauf GD, Medvedovic M. Intensity-based hierarchical Bayes method improves testing for differentially expressed genes in microarray experiments. BMC Bioinformatics. 2006;7:538. doi: 10.1186/1471-2105-7-538. [PMC free article] [PubMed] [Cross Ref]
  • Zhang An improved nonparametric approach for detecting differentially expressed genes with replicated microarray data. Stat Appl Genet Mol Biol. 2006;5:Article 30. [PubMed]
  • Hess A, Iyer H. Fisher's combined p-value for detecting differentially expressed genes using Affymetrix expression arrays. BMC Genomics. 2007;8:96. doi: 10.1186/1471-2164-8-96. [PMC free article] [PubMed] [Cross Ref]
  • Opgen-Rhein R, Strimmer K. Accurate ranking of differentially expressed genes by a distribution-free shrinkage approach. Stat Appl Genet Mol Biol. 2007;6:Article 9. [PubMed]
  • Chen JJ, Tsai CA, Tzeng S, Chen CH. Gene selection with multiple ordering criteria. BMC Bioinformatics. 2007;8:74. doi: 10.1186/1471-2105-8-74. [PMC free article] [PubMed] [Cross Ref]
  • Lo K, Gottardo R. Flexible empirical Bayes models for differential gene expression. Bioinformatics. 2007;23:328–335. doi: 10.1093/bioinformatics/btl612. [PubMed] [Cross Ref]
  • Yousef M, Jung S, Showe LC, Showe MK. Recursive cluster elimination (RCE) for classification and feature selection from gene expression data. BMC Bioinformatics. 2007;8:144. doi: 10.1186/1471-2105-8-144. [PMC free article] [PubMed] [Cross Ref]
  • Gusnanto A, Tom B, Burns P, Macaulay I, Thijssen-Timmer DC, Tijssen MR, Langford C, Watkins N, Ouwehand W, Berzuini C, Dudbridge F. Improving the power to detect differentially expressed genes in comparative microarray experiments by including information from self-self hybridizations. Comput Biol Chem. 2007;31:178–185. doi: 10.1016/j.compbiolchem.2007.03.005. [PubMed] [Cross Ref]
  • Pan W. A comparative review of statistical methods for discovering differentially expressed genes in replicated microarray experiments. Bioinformatics. 2002;18:546–554. doi: 10.1093/bioinformatics/18.4.546. [PubMed] [Cross Ref]
  • Jeffery IB, Higgins DG, Culhane AC. Comparison and evaluation of methods for generating differentially expressed gene lists from microarray data. BMC Bioinformatics. 2006;7:359. doi: 10.1186/1471-2105-7-359. [PMC free article] [PubMed] [Cross Ref]
  • Yang K, Li J, Gao H. The impact of sample imbalance on identifying differentially expressed genes. BMC Bioinformatics. 2006;7:S8. doi: 10.1186/1471-2105-7-S4-S8. [PMC free article] [PubMed] [Cross Ref]
  • Perelman E, Ploner A, Calza S, Pawitan Y. Detecting differential expression in microarray data: comparison of optimal procedures. BMC Bioinformatics. 2007;8:28. doi: 10.1186/1471-2105-8-28. [PMC free article] [PubMed] [Cross Ref]
  • Zhang S. A comprehensive evaluation of SAM, the SAM R-package and a simple modification to improve its performance. BMC Bioinformatics. 2007;8:230. doi: 10.1186/1471-2105-8-230. [PMC free article] [PubMed] [Cross Ref]
  • Claverie JM. Computational methods for the identification of differential and coordinated gene expression. Human Mol Genet. 1999;8:1821–1832. doi: 10.1093/hmg/8.10.1821. [PubMed] [Cross Ref]
  • Mutch DM, Berger A, Mansourian R, Rytz A, Roberts MA. The limit fold change model: A practical approach for selecting differentially expressed genes from microarray data. BMC Bioinformatics. 2002;3:17. doi: 10.1186/1471-2105-3-17. [PMC free article] [PubMed] [Cross Ref]
  • Quackenbush J. Microarray data normalization and transformation. Nat genet. 2002;32:496–501. doi: 10.1038/ng1032. [PubMed] [Cross Ref]
  • Belle WV, Gerits N, Jakobsen K, Brox V, Ghelue MV, Moens U. Intensity dependent confidence intervals on microarray measurements of differentially expressed genes: A case study of the effect of MK5, FKRP and TAF4 on the transcriptome. Gene Regulation Systems Biol. 2007;1:57–72. [PMC free article] [PubMed]
  • Hong F, Breitling R, McEntee CW, Wittner BS, Nemhauser JL, Chory J. RankProd: a bioconductor package for detecting differentially expressed genes in meta-analysis. Bioinformatics. 2006;22:2825–2827. doi: 10.1093/bioinformatics/btl476. [PubMed] [Cross Ref]
  • Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003;4:249–264. doi: 10.1093/biostatistics/4.2.249. [PubMed] [Cross Ref]
  • Hochreiter S, Clevert DA, Obermayer K. A new summarization method for Affymetrix probe level data. Bioinformatics. 2006;22:943–949. doi: 10.1093/bioinformatics/btl033. [PubMed] [Cross Ref]
  • Chen Z, McGee M, Liu Q, Scheuermann RH. A distribution free summarization method for Affymetrix GeneChip arrays. Bioinformatics. 2007;23:321–327. doi: 10.1093/bioinformatics/btl609. [PubMed] [Cross Ref]
  • Cope LM, Irizarry RA, Jaffee HA, Wu Z, Speed TP. A benchmark for Affymetrix GeneChip expression measures. Bioinformatics. 2004;20:323–331. doi: 10.1093/bioinformatics/btg410. [PubMed] [Cross Ref]
  • Affycomp II website http://affycomp.biostat.jhsph.edu/
  • Crimi M, Bordoni A, Menozzi G, Riva L, Fortunato F, Galbiati S, Del Bo R, Pozzoli U, Bresolin N, Comi GP. Skeletal muscle gene expression profiling in mitochondrial disorders. FASEB J. 2005;19:866–868. [PubMed]
  • Manley K, Gee GV, Simkevich CP, Sedivy JM, Atwood WJ. Microarray analysis of glial cells resistant to JCV infection suggests a correlation between viral infection and inflammatory cytokine gene expression. Virology. 2007;366:394–404. doi: 10.1016/j.virol.2007.05.016. [PMC free article] [PubMed] [Cross Ref]
  • Thalacker-Mercer AE, Fleet JC, Craig BA, Carnell NS, Campbell WW. Inadequate protein intake affects skeletal muscle transcript profiles in older humans. Am J Clin Nutr. 2007;85:1344–1352. [PMC free article] [PubMed]
  • Jin B, Tao Q, Peng J, Soo HM, Wu W, Ying J, Fields CR, Delmas AL, Liu X, Qiu J, Robertson KD. DNA methyltransferase 3B (DNMT3B) mutations in ICF syndrome lead to altered epigenetic modifications and aberrant expression of genes regulating development, neurogenesis, and immune function. Hum Mol Genet. 2008;17:690–709. doi: 10.1093/hmg/ddm341. [PubMed] [Cross Ref]
  • Hall JL, Grindle S, Han X, Fermin D, Park S, Chen Y, Bache RJ, Mariash A, Guan Z, Ormaza S, Thompson J, Graziano J, de Sam, Lazaro SE, Pan S, Simari RD, Miller LW. Genomic profiling of the human heart before and after mechanical support with a ventricular assist device reveals alterations in vascular signaling networks. Physiol Genomics. 2004;17:283–291. doi: 10.1152/physiolgenomics.00004.2004. [PubMed] [Cross Ref]
  • Viemann D, Goebeler M, Schmid S, Nordhues U, Klimmek K, Sorg C, Roth J. TNF induces distinct gene expression programs in microvascular and macrovascular human endothelial cells. J Leukoc Biol. 2006;80:174–185. doi: 10.1189/jlb.0905530. [PubMed] [Cross Ref]
  • Toruner GA, Ulger C, Alkan M, Galante AT, Rinaggio J, Wilk R, Tian B, Soteropoulos P, Hameed MR, Schwalb MN, Dermody JJ. Association between gene expression profile and tumor invasion in oral squamous cell carcinoma. Cancer Genet Cytogenet. 2004;154:27–35. doi: 10.1016/j.cancergencyto.2004.01.026. [PubMed] [Cross Ref]
  • Csoka AB, English SB, Simkevich CP, Ginzinger DG, Butte AJ, Schatten GP, Rothman FG, Sedivy JM. Genome-scale expression profiling of Hutchinson-Gilford progeria syndrome reveals widespread transcriptional misregulation leading to mesodermal/mesenchymal defects and accelerated atherosclerosis. Aging Cell. 2004;3:235–243. doi: 10.1111/j.1474-9728.2004.00105.x. [PubMed] [Cross Ref]
  • Plager DA, Leontovich AA, Henke SA, Davis MD, McEvoy MT, Sciallis GF, 2nd, Pittelkow MR. Early cutaneous gene transcription changes in adult atopic dermatitis and potential clinical implications. Exp Dermatol. 2007;16:28–36. doi: 10.1111/j.1600-0625.2006.00504.x. [PubMed] [Cross Ref]
  • Goh SH, Josleyn M, Lee YT, Danner RL, Gherman RB, Cam MC, Miller JL. The human reticulocyte transcriptome. Physiol Genomics. 2007;30:172–178. doi: 10.1152/physiolgenomics.00247.2006. [PubMed] [Cross Ref]
  • Gumz ML, Zou H, Kreinest PA, Childs AC, Belmonte LS, LeGrand SN, Wu KJ, Luxon BA, Sinha M, Parker AS, Sun LZ, Ahlquist DA, Wood CG, Copland JA. Secreted frizzled-related protein 1 loss contributes to tumor phenotype of clear cell renal cell carcinoma. Clin Cancer Res. 2007;13:4740–4749. doi: 10.1158/1078-0432.CCR-07-0143. [PubMed] [Cross Ref]
  • Reischl J, Schwenke S, Beekman JM, Mrowietz U, Sturzebecher S, Heubach JF. Increased expression of Wnt5a in psoriatic plaques. J Invest Dermatol. 2007;127:163–169. doi: 10.1038/sj.jid.5700488. [PubMed] [Cross Ref]
  • Parikh H, Carlsson E, Chutkow WA, Johansson LE, Storgaard H, Poulsen P, Saxena R, Ladd C, Schulze PC, Mazzini MJ, Jensen CB, Krook A, Bjornholm M, Tornqvist H, Zierath JR, Ridderstrale M, Altshuler D, Lee RT, Vaag A, Groop LC, Mootha VK. TXNIP regulates peripheral glucose metabolism in humans. PLoS Med. 2007;4:e158. doi: 10.1371/journal.pmed.0040158. [PMC free article] [PubMed] [Cross Ref]
  • Hsu EL, Yoon D, Choi HH, Wang F, Taylor RT, Chen N, Zhang R, Hankinson O. A proposed mechanism for the protective effect of dioxin against breast cancer. Toxicol Sci. 2007;98:436–444. doi: 10.1093/toxsci/kfm125. [PubMed] [Cross Ref]
  • Spira A, Beane J, Pinto-Plata V, Kadar A, Liu G, Shah V, Celli B, Brody JS. Gene expression profiling of human lung tissue from smokers with severe emphysema. Am J Respir Cell Mol Biol. 2004;31:601–610. doi: 10.1165/rcmb.2004-0273OC. [PubMed] [Cross Ref]
  • Wood JR, Nelson-Degrave VL, Jansen E, McAllister JM, Mosselman S, Strauss JF., 3rd Valproate-induced alterations in human theca cell gene expression: clues to the association between valproate use and metabolic side effects. Physiol Genomics. 2005;20:233–243. [PubMed]
  • Eckfeldt CE, Mendenhall EM, Flynn CM, Wang TF, Pickart MA, Grindle SM, Ekker SC, Verfaillie CM. Functional analysis of human hematopoietic stem cell gene expression using zebrafish. PLoS Biol. 2005;3:e254. doi: 10.1371/journal.pbio.0030254. [PMC free article] [PubMed] [Cross Ref]
  • Hyrcza MD, Kovacs C, Loutfy M, Halpenny R, Heisler L, Yang S, Wilkins O, Ostrowski M, Der SD. Distinct transcriptional profiles in ex vivo CD4+ and CD8+ T cells are established early in human immunodeficiency virus type 1 infection and are characterized by a chronic interferon response as well as extensive transcriptional changes in CD8+ T cells. J Virol. 2007;81:3477–3486. doi: 10.1128/JVI.01552-06. [PMC free article] [PubMed] [Cross Ref]
  • Tripathi A, King C, de la Morenas A, Perry VK, Burke B, Antoine GA, Hirsch EF, Kavanah M, Mendez J, Stone M, Gerry NP, Lenburg ME, Rosenberg CL. Gene expression abnormalities in histologically normal breast epithelium of breast cancer patients. Int J Cancer. 2008;122:1557–1566. doi: 10.1002/ijc.23267. [PubMed] [Cross Ref]
  • Wu W, Zou M, Brickley DR, Pew T, Conzen SD. Glucocorticoid receptor activation signals through forkhead transcription factor 3a in breast cancer cells. Mol Endocrinol. 2006;20:2304–2314. doi: 10.1210/me.2006-0131. [PubMed] [Cross Ref]
  • Cole SW, Hawkley LC, Arevalo JM, Sung CY, Rose RM, Cacioppo JT. Social regulation of gene expression in human leukocytes. Genome Biol. 2007;8:R189. doi: 10.1186/gb-2007-8-9-r189. [PMC free article] [PubMed] [Cross Ref]
  • Horwitz PA, Tsai EJ, Putt ME, Gilmore JM, Lepore JJ, Parmacek MS, Kao AC, Desai SS, Goldberg LR, Brozena SC, Jessup ML, Epstein JA, Cappola TP. Detection of cardiac allograft rejection and response to immunosuppressive therapy with peripheral blood gene expression. Circulation. 2004;110:3815–3821. doi: 10.1161/01.CIR.0000150539.72783.BF. [PubMed] [Cross Ref]
  • Pescatori M, Broccolini A, Minetti C, Bertini E, Bruno C, D'amico A, Bernardini C, Mirabella M, Silvestri G, Giglio V, Modoni A, Pedemonte M, Tasca G, Galluzzi G, Mercuri E, Tonali PA, Ricci E. Gene expression profiling in the early phases of DMD: a constant molecular signature characterizes DMD muscle from early postnatal life throughout disease progression. FASEB J. 2007;21:1210–1226. doi: 10.1096/fj.06-7285com. [PubMed] [Cross Ref]
  • Gomez BP, Riggins RB, Shajahan AN, Klimach U, Wang A, Crawford AC, Zhu Y, Zwart A, Wang M, Clarke R. Human X-box binding protein-1 confers both estrogen independence and antiestrogen resistance in breast cancer cell lines. FASEB J. 2007;21:4013–4027. doi: 10.1096/fj.06-7990com. [PubMed] [Cross Ref]
  • Jaworski J, Klapperich CM. Fibroblast remodeling activity at two- and three-dimensional collagen-glycosaminoglycan interfaces. Biomaterials. 2006;27:4212–4220. doi: 10.1016/j.biomaterials.2006.03.026. [PubMed] [Cross Ref]
  • Raetz EA, Perkins SL, Bhojwani D, Smock K, Philip M, Carroll WL, Min DJ. Gene expression profiling reveals intrinsic differences between T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma. Pediatr Blood Cancer. 2006;47:130–140. doi: 10.1002/pbc.20550. [PubMed] [Cross Ref]
  • Barth AS, Merk S, Arnoldi E, Zwermann L, Kloos P, Gebauer M, Steinmeyer K, Bleich M, Kaab S, Pfeufer A, Uberfuhr P, Dugas M, Steinbeck G, Nabauer M. Functional profiling of human atrial and ventricular gene expression. Pflugers Arch. 2005;450:201–208. doi: 10.1007/s00424-005-1404-8. [PubMed] [Cross Ref]
  • Barth AS, Merk S, Arnoldi E, Zwermann L, Kloos P, Gebauer M, Steinmeyer K, Bleich M, Kaab S, Hinterseer M, Kartmann H, Kreuzer E, Dugas M, Steinbeck G, Nabauer M. Reprogramming of the human atrial transcriptome in permanent atrial fibrillation: expression of a ventricular-like genomic signature. Circ Res. 2005;96:1022–1029. doi: 10.1161/01.RES.0000165480.82737.33. [PubMed] [Cross Ref]
  • Burleigh DW, Kendziorski CM, Choi YJ, Grindle KM, Grendell RL, Magness RR, Golos TG. Microarray analysis of BeWo and JEG3 trophoblast cell lines: identification of differentially expressed transcripts. Placenta. 2007;28:383–389. doi: 10.1016/j.placenta.2006.05.001. [PubMed] [Cross Ref]
  • Ryan MM, Lockstone HE, Huffaker SJ, Wayland MT, Webster MJ, Bahn S. Gene expression analysis of bipolar disorder reveals downregulation of the ubiquitin cycle and alterations in synaptic genes. Mol Psychiatry. 2006;11:965–978. doi: 10.1038/sj.mp.4001875. [PubMed] [Cross Ref]
  • Lockstone HE, Harris LW, Swatton JE, Wayland MT, Holland AJ, Bahn S. Gene expression profiling in the adult Down syndrome brain. Genomics. 2007;90:647–660. doi: 10.1016/j.ygeno.2007.08.005. [PubMed] [Cross Ref]
  • Shi L, Tong W, Fang H, Scherf U, Han J, Puri RK, Frueh FW, Goodsaid FM, Guo L, Su Z, Han T, Fuscoe JC, Xu ZA, Patterson TA, Hong H, Xie Q, Perkins RG, Chen JJ, Gasciano DA. Cross-platform comparability of microarray technology: Intra-platform consistency and appropriate data analysis procedures are essential. BMC Bioinformatics. 2005;6:S12. doi: 10.1186/1471-2105-6-S2-S12. [PMC free article] [PubMed] [Cross Ref]
  • R Foundation for Statistical Computing . R: A Language and Environment for Statistical Computing. Vienna, Austria; 2006.
  • Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JY, Zhang J. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004;5:R80. doi: 10.1186/gb-2004-5-10-r80. [PMC free article] [PubMed] [Cross Ref]
  • Hubbell E, Liu WM, Mei R. Robust estimators for expression analysis. Bioinformatics. 2002;18:1585–1592. doi: 10.1093/bioinformatics/18.12.1585. [PubMed] [Cross Ref]
  • Barrett T, Troup DB, Wilhite SE, Ledoux P, Rudnev D, Evangelista C, Kim IF, Soboleva A, Tomashevsky M, Edgar R. NCBI GEO: mining tens of millions of expression profiles – database and tools update. Nucleic Acids Res. 2007:D760–D765. doi: 10.1093/nar/gkl887. [PMC free article] [PubMed] [Cross Ref]
  • Irizarry RA, Wu Z, Jaffee HA. Comparison of Affymetrix GeneChip expression measures. Bioinformatics. 2006;22:789–794. doi: 10.1093/bioinformatics/btk046. [PubMed] [Cross Ref]
  • Kadota K, Araki R, Nakai Y, Abe M. GOGOT: a method for the identification of differentially expressed fragments from cDNA-AFLP data. Algorithm Mol Biol. 2007;2:5. doi: 10.1186/1748-7188-2-5. [PMC free article] [PubMed] [Cross Ref]
  • Katz S, Irizarry RA, Lin X, Tripputi M, Porter MW. A summarization approach for Affymetrix GeneChip data using a reference training set from a large, biologically diverse database. BMC Bioinformatics. 2006;7:464. doi: 10.1186/1471-2105-7-464. [PMC free article] [PubMed] [Cross Ref]
  • Pepper SD, Saunders EK, Edwards LE, Wilson CL, Miller CJ. The utility of MAS5 expression summary and detection call algorithms. BMC Bioinformatics. 2007;8:273. doi: 10.1186/1471-2105-8-273. [PMC free article] [PubMed] [Cross Ref]
  • Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: a practical and powerful approach to multiple testing. J Royal Stat Soc B. 1995;57:289–300.
  • Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, Sherlock G. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000;25:25–29. doi: 10.1038/75556. [PMC free article] [PubMed] [Cross Ref]
  • Kadota K, Ye J, Nakai Y, Terada T, Shimizu K. ROKU: a novel method for identification of tissue-specific genes. BMC Bioinformatics. 2006;7:294. doi: 10.1186/1471-2105-7-294. [PMC free article] [PubMed] [Cross Ref]
  • Kadota K, Nishimura SI, Bono H, Nakamura S, Hayashizaki Y, Okazaki Y, Takahashi K. Detection of genes with tissue-specific expression patterns using Akaike's Information Criterion (AIC) procedure. Physiol Genomics. 2003;12:251–259. [PubMed]
  • Kadota K, Konishi T, Shimizu K. Evaluation of two outlier-detection-based methods for detecting tissue-selective genes from microarray data. Gene Regulation Systems Biol. 2007;1:9–15. [PMC free article] [PubMed]
  • Harbron C, Chang KM, South MC. RefPlus: an R package extending the RMA algorithm. Bioinformatics. 2007;23:2493–2494. doi: 10.1093/bioinformatics/btm357. [PubMed] [Cross Ref]
  • Goldstein DR. Partition resampling and extrapolation averaging: approximation methods for quantifying gene expression in large numbers of short oligonucleotide arrays. Bioinformatics. 2006;22:2364–2372. doi: 10.1093/bioinformatics/btl402. [PubMed] [Cross Ref]
  • Konishi T. Three-parameter lognormal distribution ubiquitously found in cDNA microarray data and its application to parametric data treatment. BMC Bioinformatics. 2004;5:5. doi: 10.1186/1471-2105-5-5. [PMC free article] [PubMed] [Cross Ref]
  • The R code for the ibmT method http://eh3.uc.edu/r/ibmtR.R

Articles from Algorithms for Molecular Biology : AMB are provided here courtesy of BioMed Central

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

  • MedGen
    MedGen
    Related information in MedGen
  • PubMed
    PubMed
    PubMed citations for these articles

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...